Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Endocrine 1CNS 1

Conditions

Sarcoma 219Osteosarcoma 91Bone Neoplasms 76Gastrointestinal Stromal Tumors 67Neoplasms 55Melanoma 41Sarcoma, Ewing 32Breast Neoplasms 31Lymphoma 30Dendritic Cell Sarcoma, Interdigitating 27Leukemia 25Stomach Neoplasms 23Sarcoma, Kaposi 23Prostatic Neoplasms 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Brain Neoplasms 22Uterine Cervical Neoplasms 20Pancreatic Neoplasms 20Ovarian Neoplasms 20Neuroblastoma 20Esophageal Neoplasms 20Central Nervous System Neoplasms 20Lymphoma, Non-Hodgkin 18Lung Neoplasms 18Glioblastoma 18Desmoid Tumors 18Rhabdomyosarcoma 17Colorectal Neoplasms 17Colonic Neoplasms 17Multiple Myeloma 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Encephalocele × Sarcoma × Clear all
NCT04087902 2026-05-20

Long-Term Longitudinal QoL in Patients Undergoing EEA

Ohio State University

Active not recruiting
400 enrolled
CNSEndocrineSarcoma

Chondrosarcoma, Chordoma, Craniopharyngioma, Encephalocele, Meningioma, Pituitary Neoplasms, Esthesioneuroblastoma, Olfactory, Central Nervous System Cysts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡